Asa's Regulatory Education Series
& Guest Appearances

Asa teaches various GMP and marketing compliance classes at this three-day event.

This course reviews common product online and social media marketing pitfalls to avoid.

Regulatory topics TBD

FDA Enforcement Trends + Social Media

Asa Waldstein presents a regulatory and enforcement update on notable action happening in emerging categories such as brain health; bone, muscle, and joint health; libido; immunity; heart health; eye health; and more!

​

Asa Waldstein reviews best practices, and common mistakes companies make when marketing and labeling hemp-CBD products.

The self-proclaimed 'warning letter geek' said lately the FDA is cracking down on mental health related-claims.

In this episode, Shayda Torabi welcomes Asa Waldstein. Asa  shares about his “Warning Letter Wednesday” emails, where he breaks down the FDA warning letters. He also talks about what an FDA warning letter might be and how it plays a major role in regulating CBD products right now as hemp is federally legal.

Asa Waldstein reviews common marketing pitfalls to avoid, such as social media engagement, hashtags, reposting, product reviews, citing studies, and blogs.

Asa discusses common marketing pitfalls in the open forum presentation. This involves lots of audience participation and questions.

If you've wanted to learn more about this continually emerging, high-growth industry, Naturally Boulder has assembled a panel of experts to discuss the state of the industry, what's hot and new, and how you can develop and build a powerhouse brand in the space. I showed up as an attendee, but due to a late panelist dropout, I was asked to speak, and it was fun!

Regulatory Snapshot: A review of enforcement trends, risks, and best practices for manufacturers and marketers in the stress and mental wellness space.

In this interactive discussion, Asa Waldstein reviews common and preventable mistakes companies make when selling supplements online.

This webinar is designed to help businesses in the dietary supplement industry understand the elements of current Good Manufacturing Practice (cGMP) regulations (21 CFR 111) that are the primary focus during U.S. Food and Drug Administration (FDA) facility inspections.

Asa Waldstein joins the Atlantia team to discuss how to use clinical data for marketing purposes to overcome regulatory hurdles that many CBD companies are encountering when commercializing their innovations.

There is much that can go wrong when entering the US cannabinoid or supplement marketplace. In this session we discuss how to avoid common labeling, product manufacturing, registration, and marketing errors that can delay launches, or worse, attract the attention of the FDA and class action attorneys.

Asa Waldstein presents a regulatory and enforcement update on notable action happening in the microbiome space.

Asa Waldstein trains future regulatory compliance professionals.

This course reviews common product online and social media marketing pitfalls to avoid.

Speakers: Josh Hendrix, Jonathan Miller, Asa Waldstein, Samantha Walsh, Marielle Weintraub

Today, there are a number of congressional bills and legislative and regulatory activity that can have an impact the hemp industry. Join this expert panel for an overview and analysis of key political, policy and regulatory activity that require the hemp industry’s attention, and how producers and marketers of CBD and other cannabinoids, in particular, can remain compliant in the face of USDA, FDA, EPA and other regulatory oversight.

A 3-Day Conference for Emerging Herbal Businesses

Panel: Communicating in-store and online—where are we now?

Panel description: As COVID-19 concerns carry over into another year and consumers commit to supporting immune health year-round, the ability to communicate clearly, effectively, and legally on the topic of immune health and wellness is essential. Hear from experts on the latest need-to-know regulatory issues, winning marketing strategies, and educational strategies for retail staff and consumers. Experts will focus on getting over the "noise" of COVID with messages that resonate both short- and long-term.

In this interview Asa Waldstein will explain how CBD is regulated and how consumers can identify trustworthy companies and products.

​

Asa and Pat chat about bridging the compliance, marketing, and regulatory gap between the supplement and hemp industries.

Asa Waldstein, Founder and Principal of Supplement Advisory Group joins host Joe Witte to discuss the intersection of FDA regulations and marketing claims in the supplement and CBD industries.

This was a great conversation about the safety of dietary supplements, marketing claims, how to choose supplements, and the history of DSHEA.

Asa Waldstein and Wilson Lau explore the differences between claims that practitioners can make within their scope of practice versus ones they can make as herbal product marketers.

Join Asa Waldstein for this interactive discussion on marketing strategies, compliance, and common pitfalls to avoid.

National Industrial Hemp Council: Hemp Business Summit.
Panel Moderator: State Opportunities & Complexities

Asa discusses common marketing pitfalls in the open forum presentation. This involves lots of audience participation and questions.

Marketing and legal panel on current regulatory topics and enforcement trends in Chicago, IL.

Asa moderates a panel with industry leaders panel on Hemp-CBD, A Look at the Future Landscape.

Interactive discussion on all things hemp

Southern Hemp Expo

Level 301 CLE presentation

​

World Tea Expo Compliance Talk

Asa Waldstein moderates this FDA and FTC panel.

We discuss the cannabinoid regulatory, marketing, and enforcement trend landscape

An in-depth 3-hour workshop with Steven Yeager.